Kenan Onel
Impact in
- Oncology top 2%
- Cancer-related Molecular Pathways
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
Papers in
-
- DNA Repair Mechanisms 11
- Epigenetics and DNA Methylation 10
- Hematology 21
- Acute Myeloid Leukemia Research 11
- Co-authors
- Carlos Cordon‐Cardo (2 shared papers)Louise C. Strong (6 shared papers)Gareth L. Bond (2 shared papers)Elisabeth E. Bond (2 shared papers)Arnold J. Levine (1 shared paper)Nicoleta C. Arva (1 shared paper)Wenwei Hu (1 shared paper)Frank Bartel (1 shared paper)
- Journals
- Blood (10 papers)Biology of Blood and Marrow Transplantation (4 papers)PLoS ONE (4 papers)Cancer Management and Research (3 papers)Familial Cancer (2 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Kenan Onel
74 papers receiving 3.0k citations
Kenan Onel's Hit Papers
Peers
Comparison fields: 5 of 129
- Oncology 1.5k
- Cancer Research 567
- Hematology 408
- Molecular Biology 1.6k
- Genetics 240
Countries citing papers authored by Kenan Onel
This map shows the geographic impact of Kenan Onel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenan Onel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenan Onel more than expected).
Fields of papers citing papers by Kenan Onel
This network shows the impact of papers produced by Kenan Onel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenan Onel. The network helps show where Kenan Onel may publish in the future.
Co-authors
The 25 scholars most cited alongside Kenan Onel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in Humans Hit paper breakdown → | 2004 | 1026 |
| 2 | MDM2 and prognosis. | 2004 | 173 |
| 3 | 2013 | 171 | |
| 4 | 2004 | 158 | |
| 5 | 2014 | 124 | |
| 6 | 2011 | 116 | |
| 7 | 2010 | 84 | |
| 8 | 2017 | 80 | |
| 9 | 2017 | 69 | |
| 10 | 2020 | 68 | |
| 11 | 2009 | 65 | |
| 12 | 2012 | 61 | |
| 13 | 2015 | 61 | |
| 14 | 2016 | 60 | |
| 15 | 2008 | 57 | |
| 16 | 2021 | 56 | |
| 17 | 2015 | 54 | |
| 18 | 1994 | 52 | |
| 19 | 2007 | 42 | |
| 20 | 2015 | 37 |
About Kenan Onel
Kenan Onel is a scholar working on Molecular Biology, Hematology, Cancer Research, Oncology and Genetics, having authored 78 papers that have together received 3.1k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (15 papers), Acute Lymphoblastic Leukemia research (14 papers), Acute Myeloid Leukemia Research (11 papers), DNA Repair Mechanisms (11 papers), Cancer-related Molecular Pathways (10 papers), Epigenetics and DNA Methylation (10 papers), Genomics and Rare Diseases (9 papers) and Genetic factors in colorectal cancer (6 papers). The work is most often cited by research in Oncology (1.5k citations), Cancer Research (567 citations), Hematology (408 citations), Molecular Biology (1.6k citations) and Genetics (240 citations). Kenan Onel has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Carlos Cordon‐Cardo, Louise C. Strong, Gareth L. Bond, Elisabeth E. Bond, Arnold J. Levine, Nicoleta C. Arva, Wenwei Hu, Frank Bartel, Helge Täubert and Guillermina Lozano. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, PLoS ONE, Cancer Management and Research and Familial Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.